Ledger.Open graph →
SEC Form D · filed July 9, 2021

Castle Creek Biosciences, Inc

Offering
$25.0M
Sold
$25.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Exton, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

W. B. Middlekauff · Exton, PAExecPatrick J. Morris · Chicago, ILExec · DirectorJeffrey S. Aronin · Chicago, ILDirectorMary B. Spellman · Exton, PAExecMatthew J. Gantz · Exton, PAExec · DirectorAntonio J. Gracias · Chicago, ILDirectorGregory J. Macmichael · Exton, PAExecJennie Choboter · VANCOUVER, British Columbia, CanadaExecMichael Parton · Grand Cayman, Cayman IslandsExec · DirectorNate Armstrong · Sarasota, FLDirectorErika L. Taylor · DENVER, CODirectorPedro Checa · Kirkland, WAExecSD Ariston Manager, LLC · Akron, OHExec · DirectorGregory B. Wujek · Exton, PAExecSharon R. Malka · Yavne, L3Exec · DirectorStephen T. Wills · Yavne, L3ExecMike Knauss · New York, NYDirectorAndrew Atherton · Tempe, AZExecSue Payton · Broomfield, COExec · DirectorJeff Babione · Broomfield, CODirectorGregory J. Macmichael · Exton, PAExecGregory B. Wujek · Exton, PAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗